In recent months, UnitedHealth Group has raised premiums by around 20–30%, updated its 2025 earnings guidance, and faced ...

Discover why UnitedHealth stock rebounded after a sharp decline, future growth prospects, and how strategic changes may offer ...

UnitedHealth Group has agreed to sell its last South American business Banmedica to Brazilian private equity group Patria ...

UnitedHealth Group stock is a top dividend growth stock with solid returns, reliable yield, and long-term growth prospects.

Shares of the healthcare giant are still down more than 30% year to date, after plunging as much as 53% at one point. Should ...

Mairs & Power, an investment advisor, released the third-quarter 2025 investor letter for the “Mairs & Power Balanced Fund.” A copy of the letter can be downloaded here. As we move into 2025, the ...

UnitedHealth Group, the company that owns healthcare conglomerate UnitedHealth, said on Thursday that it is cooperating with the federal government as it fields criminal and civil requests from ...

UnitedHealth Group has reached a deal to sell its Latin American business Banmedica for $1 billion, according to media ...

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. UnitedHealth Group profits fell to $3.4 billion in the second quarter as ...

UnitedHealth's decision to exit 100-plus Medicare Advantage plans was a prudent move. The stock could have significant upside potential as its bottom line improves. One key wild card for UnitedHealth, ...

Former UnitedHealth Group CEO William McGuire joins mediation team for Fairview and University of Minnesota merger negotiations.

UNH trades below its five-year median P/E as it navigates margin pressure, membership declines and strategic divestments.